adalimumab Turanci (Q348260)
Jump to navigation
Jump to search
pharmaceutical drug Turanci
Language | Label | Description | Also known as |
---|---|---|---|
Hausa | Ba suna a kai |
Ba'a bayyana ma'ana ba |
|
Turanci | adalimumab |
pharmaceutical drug |
|
Statements
1 reference
defined daily dose Turanci
2.9 milligram
route of administration Turanci
active ingredient in Turanci
medical condition treated Turanci
osteoarthritis susceptibility 1 Turanci
legal status (medicine) Turanci
boxed warning Turanci
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)
pregnancy category Turanci
LiverTox likelihood score Turanci
1 reference
retrieved Turanci
8 Afirilu 2021
last update Turanci
10 Faburairu 2017
has characteristic Turanci
subject has role Turanci
1 reference
stated in Turanci
Medical Subject Headings Turanci
MeSH descriptor ID Turanci
retrieved Turanci
15 Maris 2018
anti-inflammatory agent Turanci
1 reference
stated in Turanci
Medical Subject Headings Turanci
MeSH descriptor ID Turanci
retrieved Turanci
15 Maris 2018
related image Turanci
Commons category Turanci
Adalimumab
0 references
Identifiers
CAS Registry Number Turanci
1 reference
ChEMBL ID Turanci
HSDB ID Turanci
1 reference
stated in Turanci
Hazardous Substances Data Bank Turanci
28 Oktoba 2019
Adalimumab (Turanci)
retrieved Turanci
10 Mayu 2021
LiverTox ID Turanci
EC number Turanci
695-701-7
1 reference
stated in Turanci
ECHA Substance Infocard database Turanci
retrieved Turanci
27 Disamba 2018
Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer (Turanci)
quotation Turanci
CAS no.: 331731-18-1 (Turanci)
ECHA Substance Infocard ID Turanci
1 reference
stated in Turanci
ECHA Substance Infocard database Turanci
retrieved Turanci
27 Disamba 2018
Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer (Turanci)
quotation Turanci
CAS no.: 331731-18-1 (Turanci)
1 reference
Guide to Pharmacology Ligand ID Turanci
MeSH descriptor ID Turanci
RxNorm ID Turanci
DrugBank ID Turanci
MedlinePlus drug identifier Turanci
PatientsLikeMe treatment ID Turanci
NDF-RT ID Turanci
KEGG ID Turanci
CAB ID Turanci
Freebase ID Turanci
Microsoft Academic ID Turanci
OpenAlex ID Turanci
1 reference
retrieved Turanci
26 Janairu 2022
Quora topic ID Turanci
ScienceDirect topic ID Turanci
WikiProjectMed ID Turanci
Sitelinks
Wikipedia(28 entries)
- arwiki أداليموماب
- azbwiki آدالیمومب
- cawiki Adalimumab
- cswiki Adalimumab
- dewiki Adalimumab
- enwiki Adalimumab
- eswiki Adalimumab
- fawiki آدالیمومب
- fiwiki Adalimumabi
- frwiki Adalimumab
- hewiki אדלימומאב
- idwiki Adalimumab
- itwiki Adalimumab
- jawiki アダリムマブ
- kowiki 아달리무맙
- nlwiki Adalimumab
- orwiki ଆଡାଲିମୁମାବ
- plwiki Adalimumab
- ptwiki Adalimumabe
- ruwiki Адалимумаб
- shwiki Adalimumab
- slwiki Adalimumab
- srwiki Adalimumab
- svwiki Humira
- trwiki Adalimumab
- ukwiki Адалімумаб
- viwiki Adalimumab
- zhwiki 阿達木單抗
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Wasu shafuka(1 entry)
- commonswiki Category:Adalimumab